Samsara BioCapital’s BCLS Acquisition Corp. Class A Ordinary Shares BLSA Stock Holding History

Samsara BioCapital’s Portfolio BLSA Stock Details BLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-300,000	Closed	-$3.01M	–	57
2022 Q3	$3.01M	Hold	300,000	–	–	0.7%	29
2022 Q2	$2.97M	Hold	300,000	–	–	0.79%	27
2022 Q1	$2.96M	Hold	300,000	–	–	0.75%	32
2021 Q4	$2.94M	Hold	300,000	–	–	0.57%	31
2021 Q3	$2.99M	Hold	300,000	–	–	0.47%	35
2021 Q2	$3.16M	Hold	300,000	–	–	0.39%	37
2021 Q1	$3.17M	Hold	300,000	–	–	0.58%	35
2020 Q4	$3.34K	Buy	+300,000	New	+$3.22M	0.34%	29

Samsara BioCapital's BLSA Position: Q4 2022 in Review

Samsara BioCapital sold out of BCLS Acquisition Corp. Class A Ordinary Shares (BLSA) in Q4 2022, closing a stake of 300,000 shares — an estimated $3.01M sold.

Samsara BioCapital first reported a position in BLSA in Q4 2020 and held it in 8 quarters. The position peaked at $3.17M in Q1 2021. 0 funds tracked by Wall St. Rank hold BLSA as of Q4 2022.

Samsara BioCapital reported no remaining BCLS Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Samsara BioCapital sold 300,000 BCLS Acquisition Corp. Class A Ordinary Shares shares in Q4 2022, an estimated $3.01M.
Samsara BioCapital first reported a position in BCLS Acquisition Corp. Class A Ordinary Shares in Q4 2020 and held it in 8 quarters.
Samsara BioCapital's BCLS Acquisition Corp. Class A Ordinary Shares position peaked at $3.17M in Q1 2021.
0 funds tracked by Wall St. Rank held BCLS Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on Samsara BioCapital's 13F filing for Q4 2022, filed 14 Feb 2023.